替换兔出血症病毒VP60表面环的嵌合病毒样颗粒可抵御两种血清型兔出血症病毒
研究用替换策略改造兔出血症病毒主要抗原蛋白VP60的表面环,经重组杆状病毒表达系统表达嵌合VP60并成功组装为病毒样颗粒(VLPs)。嵌合VLPs免疫可有效保护兔抵抗GI.1和GI.2两种强毒株致死攻击,效果与含两种野生型VLPs的混合疫苗相当。
要点
- 嵌合VP60经重组杆状病毒表达系统表达并组装为病毒样颗粒(VLPs)。
- 嵌合VLPs在电镜下呈现典型天然病毒大小和形态。
- 嵌合VLPs免疫可保护兔抵抗GI.1和GI.2强毒株致死攻击,效果与两种野生型VLPs混合疫苗相当。
核心结论
- 嵌合VLPs免疫可有效保护兔抵抗GI.1和GI.2两种强毒株致死攻击,效果与含两种野生型VLPs的混合疫苗相当。
- 研究结果表明,该策略为开发成本效益好、制备流程简便的兔出血症广谱疫苗提供了有前景的方向。
研究设计与样本
- 研究采用替换策略靶向兔出血症病毒主要抗原蛋白VP60的表面环,构建广谱嵌合抗原疫苗。
- 嵌合VP60抗原由重组杆状病毒表达系统表达,并成功组装为病毒样颗粒(VLPs)。
主要发现
- 嵌合VLPs在电镜下呈现典型天然病毒大小和形态。
- 嵌合VLPs免疫可有效保护兔抵抗GI.1和GI.2强毒株致死攻击。
- 嵌合VLPs的保护效果与含两种野生型VLPs的混合疫苗相当。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, the rabbit hemorrhagic disease virus 2(RHDV GI.2) has rapidly spread worldwide due to its broad natural host range, strong pathogenicity, and significant antigenic differences from the traditional RHDV1 (GI.1). The widespread prevalence of both GI.1 and GI.2 RHDV poses a serious threat to the healthy development of the global rabbit industry. Despite this, there is still a notable absence of effective multivalent or broad-spectrum vaccines for controlling RHD(GI.1 and GI.2). In the present study, we developed a broad-spectrum chimeric antigen vaccine using a substitution strategy targeting the surface loop of the main antigen protein VP60 of RHDV. The chimeric VP60 antigen, expressed by a recombinant baculovirus expression system, was successfully assembled into virus-like particles (VLPs). The VLPs exhibited typical natural virus size and morphology under an electron microscope. Immunization with chimeric VLPs effectively protected rabbits from lethal challenged by both virulent strains of RHDV, GI.1 and GI.2, showing an effect comparable to that of a mixture vaccine containing two wild-type VLPs. These findings demonstrate a promising strategy for developing a cost-effective and straightforward preparation process for broad-spectrum vaccine against RHD.
引用
- Xiang W, Pan B, Hao Y, et al. Chimeric virus-like particles replacing the loop on the surface of VP60 from rabbit hemorrhagic disease virus (RHDV) provide protection against two serotypes of RHDV. Vaccine. 2025. PMID: 40614613. doi:10.1016/j.vaccine.2025.127427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。